Executive Leadership, Management, Coach, Consultant, Sales
SP
Strike Photonics
Strike Photonics develops photonic chips utilizing Raman spectroscopy for rapid, non-destructive bio-diagnostics, enabling accurate detection of pathogens such as SARS-CoV-2 and influenza within minutes. Their technology addresses the need for cost-effective, field-deployable testing solutions that provide real-time results without the use of chemicals or reagents.
- Biotechnology
- Hardware
- Healthcare Technology
- Medical Devices
- Semiconductor
Updated 7 months ago
Funding
Raised to date
$16.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 3 rounds
$1.8M · Series A
Announced Apr 2023
Disclosed cumulative: $16.9M
3/3
RoundDateAmountValuationInvestors
Founders
Product
Problem
Traditional pathogen detection methods often require laboratory infrastructure, trained personnel, and time-consuming processes, hindering rapid response in point-of-care or field settings. Existing diagnostic techniques may also rely on reagents or chemicals, adding complexity and potential for errors.
Solution
Strike Photonics develops photonic chips that utilize Raman spectroscopy to enable rapid and non-destructive bio-diagnostics. Their technology facilitates the accurate detection and differentiation of pathogens, such as SARS-CoV-2 and influenza viruses, within minutes. The photonic chips are designed for cost-effective, field-deployable testing solutions that provide real-time results without the need for chemicals or reagents. By leveraging semiconductor manufacturing scale and efficiency, Strike Photonics aims to bring transformative performance to biotechnology and other sectors.
Target Audience
The primary target audience includes medical diagnostic device manufacturers, healthcare providers, and organizations requiring rapid pathogen detection for applications such as COVID-19 testing, drug screening, toxicology, and remote patient monitoring.
Features
- Rapid testing (3-5 minutes) based on Raman spectroscopy
- High accuracy (96-99%) without the use of chemicals or reagents
- Multiplexed method for detection and differentiation of multiple pathogens from a single sample
- Test card format with no expiration date
- Real-time results displayed as a heatmap
- Field-deployable design for point-of-care applications
- Semiconductor manufacturing and state-of-the-art packaging